Drug Type Synthetic peptide |
Synonyms NT-2 (Neurotez) |
Target |
Mechanism A22: Presenilin modulators, CLIP1 modulators(CAP-Gly domain containing linker protein 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | - |